Clinical Trial Update: Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating activated prothrombin complex concentrate for preventing bleeds in Hemophilia A patients with inhibitors has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Snippet

Sponsor: Tulane University School of Medicine | Conditions: Hemophilia A With Inhibitors | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-02-06